The death receptor agonists TRAIL and TWEAK have also been implicated in adult stroke models [41], [42] and we recently found that TRAIL–Death Receptor signaling is involved in hypoxic–ischemic brain injury [36]. Here, TNFSF10 is linked to stroke disorder.